Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy, Volume 181 (Hardcover)

Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy, presents the collation of chapters written by eminent scientists worldwide. CRISPR-Cas9 is a key technology for targeted genome editing and regulation in a number of organisms including mammalian cells. It is a rapid, simple, and cost-effective solution. CRISPR-Cas system has recently gained much scientific and public attention. This volume covers CRISPR-Cas9 based mammalian genome editing, creating disease models, cancer therapy, neurological, heredity, blood disorders, defective gene correction, stem cells therapy, epigenetic modifications, patents, ethics, biosafety and regulatory issues challenges and opportunities. This book is a key source of information on mammalian genome editing available in a single volume. This book will be useful for beginners in mammalian genome editing and also students, researchers, scientists, policymakers, clinicians and stakeholders interested in genome editing in several areas.

General

Imprint:	Academic Press Inc
Country of origin:	United Kingdom
Series:	Progress in Molecular Biology and Translational Science
Release date:	July 2021
First published:	2021
Volume editors:	Vijai Singh
Dimensions:	229 x 152 x 24mm (L x W x T)
Format:	Hardcover
Pages:	390
ISBN-13:	978-0-323-85323-1
Categories:	Books > Science & Mathematics > Biology, life sciences > Molecular biology Books > Science & Mathematics > Biology, life sciences > Biochemistry > General Promotions
LSN:	0-323-85323-4
Barcode:	9780323853231

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!